vs
Side-by-side financial comparison of Better Home & Finance Holding Co (BETR) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Better Home & Finance Holding Co is the larger business by last-quarter revenue ($44.3M vs $39.6M, roughly 1.1× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -3349.0%, a 3384.9% gap on every dollar of revenue. On growth, Better Home & Finance Holding Co posted the faster year-over-year revenue change (77.4% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-167.8M). Over the past eight quarters, Better Home & Finance Holding Co's revenue compounded faster (41.1% CAGR vs -15.0%).
Bajaj Finance Limited (BFL) is an Indian deposit-taking non-banking financial company (NBFC-UL) headquartered in Pune. It has 110.64 million customers and holds assets under management worth ₹462,250 crore (US$55 billion), as of September 2025.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
BETR vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.3M | $39.6M |
| Net Profit | $-39.9M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | -3376.8% | 32.5% |
| Net Margin | -3349.0% | 35.9% |
| Revenue YoY | 77.4% | -10.9% |
| Net Profit YoY | 32.6% | 117.2% |
| EPS (diluted) | $-2.52 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.3M | $39.6M | ||
| Q3 25 | $43.9M | $43.4M | ||
| Q2 25 | $44.1M | $43.4M | ||
| Q1 25 | $32.6M | $47.3M | ||
| Q4 24 | $25.0M | $44.4M | ||
| Q3 24 | $29.0M | $53.1M | ||
| Q2 24 | $32.3M | $53.1M | ||
| Q1 24 | $22.3M | $54.8M |
| Q4 25 | $-39.9M | $14.2M | ||
| Q3 25 | $-39.1M | $12.8M | ||
| Q2 25 | $-36.3M | $2.5M | ||
| Q1 25 | $-50.6M | $21.5M | ||
| Q4 24 | $-59.2M | $6.5M | ||
| Q3 24 | $-54.2M | $2.8M | ||
| Q2 24 | $-41.4M | $18.5M | ||
| Q1 24 | $-51.5M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -3376.8% | 32.5% | ||
| Q3 25 | -88.9% | 36.6% | ||
| Q2 25 | -81.9% | 33.6% | ||
| Q1 25 | -154.9% | 51.1% | ||
| Q4 24 | -1428.3% | 10.6% | ||
| Q3 24 | -186.5% | 26.1% | ||
| Q2 24 | -127.6% | 51.4% | ||
| Q1 24 | -230.8% | 44.6% |
| Q4 25 | -3349.0% | 35.9% | ||
| Q3 25 | -89.2% | 29.6% | ||
| Q2 25 | -82.2% | 5.7% | ||
| Q1 25 | -155.3% | 45.4% | ||
| Q4 24 | -1437.5% | 14.7% | ||
| Q3 24 | -187.0% | 5.3% | ||
| Q2 24 | -128.2% | 34.8% | ||
| Q1 24 | -231.4% | 34.2% |
| Q4 25 | $-2.52 | $0.15 | ||
| Q3 25 | $-2.56 | $0.12 | ||
| Q2 25 | $-2.39 | $0.02 | ||
| Q1 25 | $-3.33 | $0.21 | ||
| Q4 24 | $-3.92 | $0.05 | ||
| Q3 24 | $-3.58 | $0.03 | ||
| Q2 24 | $-2.74 | $0.20 | ||
| Q1 24 | $-3.41 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $203.4M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $37.2M | $248.3M |
| Total Assets | $1.5B | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $203.4M | $164.1M | ||
| Q3 25 | $205.8M | $127.4M | ||
| Q2 25 | $221.5M | $152.7M | ||
| Q1 25 | $228.0M | $132.1M | ||
| Q4 24 | $264.9M | $125.0M | ||
| Q3 24 | $262.1M | $137.4M | ||
| Q2 24 | $378.8M | — | ||
| Q1 24 | $482.6M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $37.2M | $248.3M | ||
| Q3 25 | $41.9M | $248.0M | ||
| Q2 25 | $76.6M | $244.6M | ||
| Q1 25 | $-102.1M | $226.4M | ||
| Q4 24 | $-58.2M | $195.1M | ||
| Q3 24 | $388.0K | $205.0M | ||
| Q2 24 | $44.9M | $8.8M | ||
| Q1 24 | $76.3M | $9.0M |
| Q4 25 | $1.5B | $380.4M | ||
| Q3 25 | $1.4B | $321.4M | ||
| Q2 25 | $1.2B | $315.3M | ||
| Q1 25 | $1.0B | $284.6M | ||
| Q4 24 | $913.1M | $266.1M | ||
| Q3 24 | $845.2M | $296.5M | ||
| Q2 24 | $957.9M | $19.5M | ||
| Q1 24 | $841.6M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-166.6M | $52.0M |
| Free Cash FlowOCF − Capex | $-167.8M | $51.2M |
| FCF MarginFCF / Revenue | -378.6% | 129.3% |
| Capex IntensityCapex / Revenue | 2.7% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | $-277.9M | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-166.6M | $52.0M | ||
| Q3 25 | $4.2M | $-20.9M | ||
| Q2 25 | $-56.3M | $-8.3M | ||
| Q1 25 | $-57.2M | $1.9M | ||
| Q4 24 | $-380.0M | $-7.3M | ||
| Q3 24 | $-10.6M | $5.0M | ||
| Q2 24 | $-220.6M | $19.2M | ||
| Q1 24 | $-42.8M | $3.7M |
| Q4 25 | $-167.8M | $51.2M | ||
| Q3 25 | $4.0M | $-20.9M | ||
| Q2 25 | $-56.7M | $-8.6M | ||
| Q1 25 | $-57.4M | $1.7M | ||
| Q4 24 | $-383.4M | $-7.9M | ||
| Q3 24 | $-11.7M | $4.6M | ||
| Q2 24 | $-221.8M | $18.3M | ||
| Q1 24 | $-43.3M | $3.0M |
| Q4 25 | -378.6% | 129.3% | ||
| Q3 25 | 9.1% | -48.3% | ||
| Q2 25 | -128.5% | -19.9% | ||
| Q1 25 | -176.3% | 3.5% | ||
| Q4 24 | -1534.6% | -17.8% | ||
| Q3 24 | -40.5% | 8.7% | ||
| Q2 24 | -687.6% | 34.5% | ||
| Q1 24 | -194.5% | 5.4% |
| Q4 25 | 2.7% | 2.0% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.9% | 0.7% | ||
| Q1 25 | 0.6% | 0.5% | ||
| Q4 24 | 13.6% | 1.3% | ||
| Q3 24 | 4.1% | 0.8% | ||
| Q2 24 | 3.9% | 1.6% | ||
| Q1 24 | 2.1% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | — | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BETR
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
